Clinical Hospital Centre "Sestre Milosrdnice"

Zagreb 10000

0 studies enrolling now · 3 studies all time

What they study most

Locally Advanced or Metastatic Unresectable Urothelial Cancer, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed